Study of Low-level Laser Therapy in the Acute Treatment of Migraine

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Migraine Headache

In brief

This study evaluates the treatment of migraine pain using low energy laser light to quench migraine signals issuing from the sphenopalatine ganglion (SPG).

Key facts

Study ID

NCT02969642

Run by

The San Francisco Clinical Research Center

People needed

60

Starts

2016-03-01

Expected to finish

2017-07-01

Last updated by the study team

2016-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• male or female
• aged 18 or older;
• subject diagnosed with migraine according to The International Classification of Headache Disorders- Version 3;
• 1-20 headache days per month;
• history of at least moderate pain if migraine left untreated.

You may not qualify if…

• headache on greater than 25 days/month on average for preceding 3 months;
• headache on greater than 25 days in present month;
• headache attributed to: head or neck trauma, cluster headache, specific migraine variants such as basilar artery, ophthalmoplegic, hemiplegic, etc;
• women of child bearing age not using acceptable method of contraception;
• pregnant or nursing women;
• history of malignancy of any organ
• uncontrolled: hypertension, severe psychiatric disorders, or known use of narcotics, analgesic or alcohol abuse;
• light sensitivity;
• retinal disease;
• intranasal pathology.

Where it is running

• San Francisco Clinical Research Center — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.